SCHEMBL6208518

SCHEMBL6208518

CCCC(Cl)N=C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9344519 0.86
SCHEMBL8574940 0.84 MAPT (0.36)
SCHEMBL11591054 0.82 MAPT (0.39)
SCHEMBL28617835 0.82
SCHEMBL1985836 0.81
SCHEMBL28617838 0.79
SCHEMBL11039419 0.78 ALDH1A1 (0.30)
SCHEMBL28611757 0.75
SCHEMBL6184126 0.74 CYP3A4 (0.33)
SCHEMBL34776 0.74 CHRM1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108997504-B Preparation method of ionic liquid functionalized cellulose carbamate material 贵州大学 2021-05-07 CN claimed
CN-108997504-B Preparation method of ionic liquid functionalized cellulose carbamate material 贵州大学 2021-05-07 CN disclosed
CN-103980151-A Novel compounds as antagonists or inverse agonists at opioid receptors SMITHKLINE BEECHAM CORP 2014-08-13 CN disclosed
CN-101522614-B Compounds as antagonists or inverse agonists of opioid receptors SMITHKLINE BEECHAM CORP 2014-06-25 CN disclosed
CN-102516115-A Novel compounds as antagonists or inverse agonists at opioid receptors SMITHKLINE BEECHAM CORP 2012-06-27 CN disclosed
CN-101522614-A Novel compounds as antagonists or inverse agonists of opioid receptors SMITHKLINE BEECHAM CORP (US) 2009-09-02 CN disclosed
EP-0865283-A4 2-DEOXYSTREPTAMINE AS A MOLECULAR SCAFFOLD FOR PREPARING FUNCTIONALLY AND SPACIALLY DIVERSE MOLECULES AND PHARMACEUTICAL COMPOSITIONS THEREOF ANADYS PHARMACEUTICALS INC (US) 2005-07-20 EP disclosed
EP-1178048-B1 Azabicycloalkane derivatives for use as serotonin reuptake inhibitors and 5HT2a antagonists PFIZER PROD INC (US) 2005-06-15 EP disclosed
US-6552015-B2 Inhibition of serotonin reuptake; especially 2-(azabicycloalkyl)alkylenyl)isoquinolin-3-one compounds PFIZER INC. 2003-04-22 US disclosed
US-20020052355-A1 Azabicycloalkane derivatives and therapeutic uses thereof PFIZER PRODUCTS INC. 2002-05-02 US disclosed
EP-1178048-A1 Azabicycloalkane derivatives for use as serotonin reuptake inhibitors and 5HT2a antagonists Pfizer Products Inc. (US) 2002-02-06 EP disclosed
EP-0865283-A1 2-DEOXYSTREPTAMINE AS A MOLECULAR SCAFFOLD FOR PREPARING FUNCTIONALLY AND SPACIALLY DIVERSE MOLECULES AND PHARMACEUTICAL COMPOSITIONS THEREOF Scriptgen Pharmaceuticals Inc. (US) 1998-09-23 EP disclosed
WO-1997009053-A1 2-DEOXYSTREPTAMINE AS A MOLECULAR SCAFFOLD FOR PREPARING FUNCTIONALLY AND SPATIALLY DIVERSE MOLECULES AND PHARMACEUTICAL COMPOSITIONS THEREOF SCRIPTGEN PHARMACEUTICALS, INC. (US) 1997-03-13 WO disclosed
EP-0433806-B1 Isocyanatoalkylsulfonates and process for their preparation BAYER AG (DE) 1994-06-22 EP disclosed
US-5110975-A ISOCYANATOALKYL SULPHONATES AND A PROCESS FOR THEIR PREPARATION BAYER AKTIENGESELLSCHAFT (DE) 1992-05-05 US disclosed
EP-0433806-A2 Isocyanatoalkylsulfonates and process for their preparation BAYER AG (DE) 1991-06-26 EP disclosed